Finance and funding: latest news

Finance and funding features

Finance and funding news from aidsmap

More news

Finance and funding news selected from other sources

  • A reduction in new HIV diagnoses is no reason to reduce effort

    The drop in new diagnoses among gay and bisexual men must be seen as an indicator of the reductions that are possible, rather than meaning that the job is done or that a downwards trajectory in new diagnoses will continue in the future. Importantly, so far these reductions have only been seen in one population group.

    15 November 2017 | The King's Fund
  • Peter Sands Named Head of Global Disease-Fighting Agency

    A former British banker was named executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday, taking over an international disease-fighting partnership that has struggled since its inception 15 years ago to raise enough money to fulfill its mission.

    15 November 2017 | New York Times
  • Peter Sands is new Global Fund executive director

    Peter Sands was announced as the new executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday. The news follows a chaotic few days during which Sands, the former CEO of Standard Chartered PLC, withdrew from the leadership race “for personal reasons” and then unexpectedly re-entered the race on Monday.

    15 November 2017 | Devex
  • £600,000 funding of 12 projects by PHE to help prevent HIV

    Public Health England (PHE) has announced the projects which have been awarded funding from the HIV Prevention Innovation Fund for 2017 to 2018. The projects have been chosen from across England to receive total funding of £600,000 from the Department of Health through PHE.

    14 November 2017 | Public Health England
  • British Columbia just lost its last two excuses not to cover the pill that prevents HIV

    Julio Montaner, the head of the BC Centre for Excellence in HIV/AIDS, told a room full of doctors and activists Nov 6, 2017, that his centre has negotiated a deal with generic drug manufacturers that could deliver the treatment without swelling the budget. “The message is, we’re ready,” Montaner told Xtra following his announcement. “It’s time to do this.”

    13 November 2017 | XTRA, Vancouver
  • Eliminating viral hepatitis: time to match visions with action

    Fundamentally, the tools needed to move towards elimination targets already exist—an effective vaccine for hepatitis B and a curative treatment for hepatitis C. What is needed now more than anything else is the political will to scale up prevention, diagnosis, and treatment programmes.

    10 November 2017 | The Lancet (editorial)
  • Vital Microbicides May Soon Be Out of Reach

    Whether, when, and how microbicide development proceeds depends on the U.S government, and the federal Division of AIDS has suggested this development may no longer be a priority. It's wrong.

    10 November 2017 | Rewire
  • US: Trump Policy Harming Kenya, Uganda Health Services

    Early effects of United States restrictions to global health aid include cuts to essential health services in Kenya and Uganda, Human Rights Watch said in a letter to US Secretary of State Rex Tillerson that was released today. The changes have resulted in a loss of training and equipment from nongovernmental groups for government health clinics, and widespread confusion about implementation. Human Rights Watch sent its findings in advance of a six-month review by the State Department of these funding restrictions.

    06 November 2017 | Human Rights Watch Health
  • Swaziland: Much still to be done as country progresses towards reaching 90.90.90 targets

    Swaziland’s HIV response is at a tipping point at this moment. There has been remarkable progress but greatest challenge the country faces now is the flat-lining of resources.

    02 November 2017 | Swazi Observer
  • Federal Budget Cuts Could Be a Disaster for HIV Patients

    Advocates have been fighting the Trump administration tooth and nail to preserve HIV/AIDS funding. So far, they've been largely successful—but experts say any lapse in budget could be a huge setback.

    01 November 2017 | Vice
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.